Loading...
Loading...
Pain Therapeutics
PTIE shares dipped 60.72% to $1.63 after Pfizer
PFE announced that it will discontinue deal on REMOXY and Pain Therapeutics will regain full development and commercial rights to REMOXY.
DURECT
DRRX shares fell 43.88% to $0.78 after Pfizer discontinued deal on REMOXY.
Akebia Therapeutics
AKBA shares declined 35.90% to $12.64 after the company reported positive top-line results from its Phase 2b study of AKB-6548 in non-dialysis patients with anemia related to chronic kidney disease.
Sarepta Therapeutics
SRPT shares tumbled 34.55% to $15.42 on the FDA requirement of additional data from Sarepta on Eteplirsen.
Precision Drilling
PDS shares slipped 9.70% to $7.99. Precision Drilling reported a 79% gain in its third-quarter profit and lifted its quarterly dividend by 17%.
Regulus Therapeutics
RGLS shares slipped 8.14% to $15.92 after jumping 19.19% on Friday.
Huntsman
HUN shares declined 4.83% to $23.32. Huntsman reported upbeat earnings for the third quarter.
GoPro
GPRO shares dropped 4.64% to $68.58 after falling 9.15% on Friday.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in